4,4'-(Propane-1,3-diylbis(oxy))bis(5-methoxy-2-nitrobenzoic acid), 95%, 1g

2-methoxy-4'-(4-methylpiperazinomethyl) benzophenone, 97.0%, 1g

2-((3-Carboxypropanoyl)oxy)-N,N,N-trimethylethanaminium chloride, 98%, 5g

4-Bromoisoquinoline, 97.0%, 500g

1,5-dimethylindole-3-carboxylic acid, 500mg

(4-(Cyclopropylcarbamoyl)phenyl)boronic acid, 95.0%, 25g

N-Boc-2-Amino-5-bromothiazole, 95.0%, 25g

(S)-(3-Hydroxy-3-(piperidin-2-yl)azetidin-1-yl)(2,3,4-trifluorophenyl)methanone hydrochloride, 97%, 1g

3-(2-METHOXYETHOXY)PROPYL BROMIDE, 95.0%, 200mg

4-Bromo-3-methylbenzyl Alcohol>98.0%(GC)1g

(R)-1-(5-Fluoro-2-methoxyphenyl)ethan-1-amine hydrochloride, 1g

GC capillary column ROTI®Cap-1701 MS, 30 m, 0.25 mm, 0.50 µm, 1 Piece(s)

Oxo(3,4,5-trimethoxyphenyl)acetic acid, 95.0%, 100mg